Vaughan HA - Search Results

1

Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies.

Wang Y, Han KJ, Pang XW, Vaughan HA, Qu W, Dong XY, Peng JR, Zhao HT, Rui JA, Leng XS, Cebon J, Burgess AW, Chen WF. Wang Y, et al. Among authors: vaughan ha. J Immunol. 2002 Jul 15;169(2):1102-9. doi: 10.4049/jimmunol.169.2.1102. J Immunol. 2002. PMID: 12097419

2

Expression of the MAGE-1 gene in human hepatocellular carcinomas.

Chen H, Cai S, Wang Y, Zhao H, Peng J, Pang X, Zhu J, Cong X, Rui J, Leng X, Du R, Wang Y, Vaughan H, Cebon J, Burgess AW, Chen W. Chen H, et al. Chin Med J (Engl). 2000 Dec;113(12):1112-8. Chin Med J (Engl). 2000. PMID: 11776148

3

The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning.

Vaughan HA, St Clair F, Scanlan MJ, Chen YT, Maraskovsky E, Sizeland A, Old LJ, Cebon J. Vaughan HA, et al. Cancer Immun. 2004 Jul 16;4:5. Cancer Immun. 2004. PMID: 15255672

4

MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma.

Gibbs P, Hutchins AM, Dorian KT, Vaughan HA, Davis ID, Silvapulle M, Cebon JS. Gibbs P, et al. Among authors: vaughan ha. Melanoma Res. 2000 Jun;10(3):259-64. Melanoma Res. 2000. PMID: 10890380

5

Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.

Vaughan HA, Svobodova S, Macgregor D, Sturrock S, Jungbluth AA, Browning J, Davis ID, Parente P, Chen YT, Stockert E, St Clair F, Old LJ, Cebon J. Vaughan HA, et al. Clin Cancer Res. 2004 Dec 15;10(24):8396-404. doi: 10.1158/1078-0432.CCR-04-0809. Clin Cancer Res. 2004. PMID: 15623618

6

Isolation and characterization of cDNA clones for mouse Ly-9.

Sandrin MS, Gumley TP, Henning MM, Vaughan HA, Gonez LJ, Trapani JA, McKenzie IF. Sandrin MS, et al. Among authors: vaughan ha. J Immunol. 1992 Sep 1;149(5):1636-41. J Immunol. 1992. PMID: 1506686

7

Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma.

Cebon J, Jäger E, Shackleton MJ, Gibbs P, Davis ID, Hopkins W, Gibbs S, Chen Q, Karbach J, Jackson H, MacGregor DP, Sturrock S, Vaughan H, Maraskovsky E, Neumann A, Hoffman E, Sherman ML, Knuth A. Cebon J, et al. Cancer Immun. 2003 Jul 16;3:7. Cancer Immun. 2003. PMID: 12862418 Clinical Trial.

8

CD48 is a low affinity ligand for human CD2.

Sandrin MS, Mouhtouris E, Vaughan HA, Warren HS, Parish CR. Sandrin MS, et al. Among authors: vaughan ha. J Immunol. 1993 Nov 1;151(9):4606-13. J Immunol. 1993. PMID: 7691954

9

The isolation of cDNA clones for CD48.

Vaughan HA, Henning MM, Purcell DF, McKenzie IF, Sandrin MS. Vaughan HA, et al. Immunogenetics. 1991;33(2):113-7. doi: 10.1007/BF00210824. Immunogenetics. 1991. PMID: 1999351

10

Association of CD7 and CD3 molecules on the T cell surface.

Sandrin MS, Vaughan HA, McKenzie IF. Sandrin MS, et al. Among authors: vaughan ha. Transplant Proc. 1989 Feb;21(1 Pt 1):103-4. Transplant Proc. 1989. PMID: 2468198 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page